Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type

Naoki Watanabe, Masayuki Haruta, Hidenobu Soejima, Daisuke Fukushi, Kinji Yokomori, Hisaya Nakadate, Hajime Okita, Jun Ich Hata, Masahiro Fukuzawa, Yasuhiko Kaneko

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

In a metaphase comparative genomic hybridization and fluorescence in situ hybridization study of 13 congenital mesoblastic nephroma (CMN) tumors, trisomy 11 was found in seven cellular or mixed type tumors, disomy 11 with other chromosome changes in two cellular type tumors, and no chromosome changes in four classical type tumors. Reverse-transcription (RT)-PCR analysis detected the ETV6-NTRK3 fusion transcript in all eight cellular or mixed type tumors examined, but not in four classical type tumors. All seven tumors with trisomy 11 showed duplication of the paternal IGF2 allele, and six cellular or classical type tumors with disomy 11 showed one paternal and one maternal allele of IGF2, analyzing the methylation status of the sixth CTCF site of the H19-differentially methylated region. Allelic expression study using the ApaI/AvaII polymorphism site at exon 9 of IGF2 showed retention of imprinting in all seven tumors examined. Quantitative real-time RT-PCR analysis showed higher expression levels of IGF2 mRNA in three of three cellular type tumors with trisomy 11, in one cellular type tumor with disomy 11, and in three of four classical tumors than in fetal kidneys or normal kidney tissues. Thus, duplicated paternal IGF2 resulted in elevated IGF2 mRNA levels, and may provide CMN or its precursor cells with a proliferative advantage. The mechanism explaining that some cellular or classical type tumors with disomy 11 also showed elevated IGF2 mRNA levels remains unresolved. IGF2 clearly plays an important role in the tumorigenic process of CMN, although it is difficult to assess its exact role.

Original languageEnglish
Pages (from-to)929-935
Number of pages7
JournalGenes Chromosomes and Cancer
Volume46
Issue number10
DOIs
Publication statusPublished - 2007 Oct
Externally publishedYes

Fingerprint

Mesoblastic Nephroma
Trisomy
Alleles
Messenger RNA
Neoplasms
Reverse Transcription
Chromosomes
Kidney
Polymerase Chain Reaction
Comparative Genomic Hybridization
Metaphase

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type. / Watanabe, Naoki; Haruta, Masayuki; Soejima, Hidenobu; Fukushi, Daisuke; Yokomori, Kinji; Nakadate, Hisaya; Okita, Hajime; Hata, Jun Ich; Fukuzawa, Masahiro; Kaneko, Yasuhiko.

In: Genes Chromosomes and Cancer, Vol. 46, No. 10, 10.2007, p. 929-935.

Research output: Contribution to journalArticle

Watanabe, Naoki ; Haruta, Masayuki ; Soejima, Hidenobu ; Fukushi, Daisuke ; Yokomori, Kinji ; Nakadate, Hisaya ; Okita, Hajime ; Hata, Jun Ich ; Fukuzawa, Masahiro ; Kaneko, Yasuhiko. / Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type. In: Genes Chromosomes and Cancer. 2007 ; Vol. 46, No. 10. pp. 929-935.
@article{516a498925df4fa6ade1403f2cd4e30b,
title = "Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type",
abstract = "In a metaphase comparative genomic hybridization and fluorescence in situ hybridization study of 13 congenital mesoblastic nephroma (CMN) tumors, trisomy 11 was found in seven cellular or mixed type tumors, disomy 11 with other chromosome changes in two cellular type tumors, and no chromosome changes in four classical type tumors. Reverse-transcription (RT)-PCR analysis detected the ETV6-NTRK3 fusion transcript in all eight cellular or mixed type tumors examined, but not in four classical type tumors. All seven tumors with trisomy 11 showed duplication of the paternal IGF2 allele, and six cellular or classical type tumors with disomy 11 showed one paternal and one maternal allele of IGF2, analyzing the methylation status of the sixth CTCF site of the H19-differentially methylated region. Allelic expression study using the ApaI/AvaII polymorphism site at exon 9 of IGF2 showed retention of imprinting in all seven tumors examined. Quantitative real-time RT-PCR analysis showed higher expression levels of IGF2 mRNA in three of three cellular type tumors with trisomy 11, in one cellular type tumor with disomy 11, and in three of four classical tumors than in fetal kidneys or normal kidney tissues. Thus, duplicated paternal IGF2 resulted in elevated IGF2 mRNA levels, and may provide CMN or its precursor cells with a proliferative advantage. The mechanism explaining that some cellular or classical type tumors with disomy 11 also showed elevated IGF2 mRNA levels remains unresolved. IGF2 clearly plays an important role in the tumorigenic process of CMN, although it is difficult to assess its exact role.",
author = "Naoki Watanabe and Masayuki Haruta and Hidenobu Soejima and Daisuke Fukushi and Kinji Yokomori and Hisaya Nakadate and Hajime Okita and Hata, {Jun Ich} and Masahiro Fukuzawa and Yasuhiko Kaneko",
year = "2007",
month = "10",
doi = "10.1002/gcc.20481",
language = "English",
volume = "46",
pages = "929--935",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - Duplication of the paternal IGF2 allele in trisomy 11 and elevated expression levels of IGF2 mRNA in congenital mesoblastic nephroma of the cellular or mixed type

AU - Watanabe, Naoki

AU - Haruta, Masayuki

AU - Soejima, Hidenobu

AU - Fukushi, Daisuke

AU - Yokomori, Kinji

AU - Nakadate, Hisaya

AU - Okita, Hajime

AU - Hata, Jun Ich

AU - Fukuzawa, Masahiro

AU - Kaneko, Yasuhiko

PY - 2007/10

Y1 - 2007/10

N2 - In a metaphase comparative genomic hybridization and fluorescence in situ hybridization study of 13 congenital mesoblastic nephroma (CMN) tumors, trisomy 11 was found in seven cellular or mixed type tumors, disomy 11 with other chromosome changes in two cellular type tumors, and no chromosome changes in four classical type tumors. Reverse-transcription (RT)-PCR analysis detected the ETV6-NTRK3 fusion transcript in all eight cellular or mixed type tumors examined, but not in four classical type tumors. All seven tumors with trisomy 11 showed duplication of the paternal IGF2 allele, and six cellular or classical type tumors with disomy 11 showed one paternal and one maternal allele of IGF2, analyzing the methylation status of the sixth CTCF site of the H19-differentially methylated region. Allelic expression study using the ApaI/AvaII polymorphism site at exon 9 of IGF2 showed retention of imprinting in all seven tumors examined. Quantitative real-time RT-PCR analysis showed higher expression levels of IGF2 mRNA in three of three cellular type tumors with trisomy 11, in one cellular type tumor with disomy 11, and in three of four classical tumors than in fetal kidneys or normal kidney tissues. Thus, duplicated paternal IGF2 resulted in elevated IGF2 mRNA levels, and may provide CMN or its precursor cells with a proliferative advantage. The mechanism explaining that some cellular or classical type tumors with disomy 11 also showed elevated IGF2 mRNA levels remains unresolved. IGF2 clearly plays an important role in the tumorigenic process of CMN, although it is difficult to assess its exact role.

AB - In a metaphase comparative genomic hybridization and fluorescence in situ hybridization study of 13 congenital mesoblastic nephroma (CMN) tumors, trisomy 11 was found in seven cellular or mixed type tumors, disomy 11 with other chromosome changes in two cellular type tumors, and no chromosome changes in four classical type tumors. Reverse-transcription (RT)-PCR analysis detected the ETV6-NTRK3 fusion transcript in all eight cellular or mixed type tumors examined, but not in four classical type tumors. All seven tumors with trisomy 11 showed duplication of the paternal IGF2 allele, and six cellular or classical type tumors with disomy 11 showed one paternal and one maternal allele of IGF2, analyzing the methylation status of the sixth CTCF site of the H19-differentially methylated region. Allelic expression study using the ApaI/AvaII polymorphism site at exon 9 of IGF2 showed retention of imprinting in all seven tumors examined. Quantitative real-time RT-PCR analysis showed higher expression levels of IGF2 mRNA in three of three cellular type tumors with trisomy 11, in one cellular type tumor with disomy 11, and in three of four classical tumors than in fetal kidneys or normal kidney tissues. Thus, duplicated paternal IGF2 resulted in elevated IGF2 mRNA levels, and may provide CMN or its precursor cells with a proliferative advantage. The mechanism explaining that some cellular or classical type tumors with disomy 11 also showed elevated IGF2 mRNA levels remains unresolved. IGF2 clearly plays an important role in the tumorigenic process of CMN, although it is difficult to assess its exact role.

UR - http://www.scopus.com/inward/record.url?scp=34548743369&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548743369&partnerID=8YFLogxK

U2 - 10.1002/gcc.20481

DO - 10.1002/gcc.20481

M3 - Article

C2 - 17639583

AN - SCOPUS:34548743369

VL - 46

SP - 929

EP - 935

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 10

ER -